Already a member? Sign in
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI). It is used for depression, general anxiety disorder, pain associated with diabetic neuropathy and for fibromyalgia.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Fibromyalgia | 2952 | 960 |
|
|
|
|
|
| Depressed mood | 1290 | 442 |
|
|
|
|
|
| Major Depressive Disorder | 608 | 121 |
|
|
|
|
|
| Pain | 427 | 142 |
|
|
|
|
|
| Chronic Fatigue Syndrome | 398 | 46 |
|
|
|
|
|
| Generalized Anxiety Disorder | 312 | 72 |
|
|
|
|
|
See all 4012 patients currently taking Duloxetine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Duloxetine
| Nausea | 138 | |
|---|---|---|
| Sex drive (libido) decreased | 125 | |
| Dizziness | 101 | |
| Sweating increased | 97 | |
| Weight gain | 91 | |
| Insomnia | 78 | |
| See all 433 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Duloxetine. See all 59 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 956 | ||
| Did not seem to work | 776 | ||
| Doctor's advice | 283 | ||
| Expense | 258 | ||
| Other | 234 | ||
| Personal research | 74 | ||
| Change in health plan coverage | 74 | ||
| Course of treatment ended | 34 | ||
| Not indicated | 22 |
Adherence
Taking treatment as prescribed
Adherence of Duloxetine
Always |
1392 | 85% |
|
|---|---|---|---|
Usually |
156 | 10% |
|
Sometimes |
19 | 1% |
|
Never |
69 | 4% |
|
Burden
Difficulty being on treatment
Burden of Duloxetine
Very |
119 | 7% |
|
|---|---|---|---|
Somewhat |
148 | 9% |
|
A little |
212 | 13% |
|
Not at all |
1157 | 71% |
|
Cost
Paid out of pocket
Cost of Duloxetine
$200+ |
30 | 3% |
|
|---|---|---|---|
$100-199 |
92 | 8% |
|
$50-99 |
200 | 18% |
|
$25-49 |
333 | 30% |
|
< $25 |
441 | 40% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 26, 2012.